News

Latest industry news and developments

June 25, 2024

Guiding Principles for Transparent Machine Learning in Medical Devices

The FDA, Health Canada, and the UK's MHRA have established guiding principles to enhance transparency in machine learning-enabled medical devices (MLMDs). These principles focus on clear communication about a device's use, development, performance, and decision-making logic to ensure safe and effective patient care. Human-centered design is emphasized to make information accessible and understandable for all users.

June 19, 2024

SCHEER Updates Guidelines on Phthalates in Medical Devices

Phthalates, widely used as plasticizers in various industries, pose health risks due to their weak interaction with polymers, leading to potential human exposure. The Scientific Committee on Health, Environmental, and Emerging Risks (SCHEER) has released updated guidelines on the benefit-risk assessment (BRA) of phthalates in medical devices. These guidelines focus on phthalates that are carcinogenic, mutagenic, toxic to reproduction (CMR), or have endocrine-disrupting (ED) properties. The revisions, the first since the guidelines were published in 2019, incorporate new regulatory developments, updated methods, and enhanced evaluation frameworks based on recent scientific data and experiences.

May 27, 2024

Changes in the guidance on MDR appropriate surveillance – MDCG 2022-4 Rev. 2

According to Article 120(3e) of the MDR, the notified body that issued your MDD or AIMDD certificate is still responsible for monitoring your devices to make sure they meet the necessary requirements. This means that their surveillance activities will continue as they did before under the previous Directives. The revised guidance regarding the transitional provisions […]

May 10, 2024

MHRA launches AI Airlock to address challenges for medical devices that use Artificial Intelligence

Last month, the MHRA outlined its strategy for regulating AI in response to a government white paper. This new pilot project aims to address challenges in regulating standalone AI medical devices (AIaMD) by initially supporting 4-6 projects. The goal is to test regulatory issues for these devices when used in the NHS. The regulatory sandbox […]

April 25, 2024

Information from Swiss Medtech on placing on the market

During the shift from MDD to MDR, MDD-compliant devices can only be introduced into the Swiss market until a specified date. Consequently, there's a potential scenario where certain products currently stocked in Swiss warehouses may become unsellable on May 27, 2024. To mitigate this risk, Swiss Medtech has developed a guidance document.

CONTACT US